Form D · Other
TIANYIN PHARMACEUTICAL CO., INC.
Chengdu, P.R., F4 · CIK 0001362718
Offering snapshot reported Nov 20, 2009 · SEC filing
- Reported sold
- $5M Offering amount: $5M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $3.5M Reported outside-investor minimum
- First sale
- Oct 27, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 20, 2009 | Initial | $5,000,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $495K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-136310
Source: Form D, filed Nov 20, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Quoqing Jiang | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
23 Rd Floor, Unionsun Yangkuo Plaza No.2, Block 3, Renmin Road South
Chengdu, P.R., F4, 610041
Chengdu, P.R., F4, 610041